These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25063555)

  • 41. Cluster effects to the design and analysis of a randomised trial.
    Yudkin P
    Fam Pract; 1998 Jun; 15(3):289. PubMed ID: 9694190
    [No Abstract]   [Full Text] [Related]  

  • 42. Researchers should convince policy makers to perform a classic cluster randomized controlled trial instead of a stepped wedge design when an intervention is rolled out.
    Kotz D; Spigt M; Arts IC; Crutzen R; Viechtbauer W
    J Clin Epidemiol; 2012 Dec; 65(12):1255-6. PubMed ID: 22964069
    [No Abstract]   [Full Text] [Related]  

  • 43. The stepped wedge design does not inherently have more power than a cluster randomized controlled trial.
    Kotz D; Spigt M; Arts IC; Crutzen R; Viechtbauer W
    J Clin Epidemiol; 2013 Sep; 66(9):1059-60. PubMed ID: 23953488
    [No Abstract]   [Full Text] [Related]  

  • 44. Context by treatment interactions as the primary object of study in cluster randomized controlled trials of population health interventions.
    Fuller D; Potvin L
    Int J Public Health; 2012 Jun; 57(3):633-6. PubMed ID: 22438082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of the "m" in the cmRCT (cohort multiple randomized controlled trial) design revealed dependence between trial results.
    Groenwold RHH; van Smeden M
    J Clin Epidemiol; 2018 Sep; 101():119-123. PubMed ID: 29705095
    [No Abstract]   [Full Text] [Related]  

  • 46. How Cluster RCTs Work.
    Li S; Hardin CC; Fralick M; Muller D; Koscal N; Normand SL; Sacks CA
    NEJM Evid; 2024 May; 3(5):EVIDstat2400139. PubMed ID: 38815163
    [No Abstract]   [Full Text] [Related]  

  • 47. Correction: A Hybrid Pragmatic and Factorial Cluster Randomized Controlled Trial for an Anti-racist, Multilevel Intervention to Improve Mental Health Equity in High Schools.
    Mulawa MI; Docherty SL; Bailey DE; Gonzalez-Guarda RM; Lipkus IM; Randolph SD; Yang Q; Pan W
    Prev Sci; 2024 Mar; ():. PubMed ID: 38536537
    [No Abstract]   [Full Text] [Related]  

  • 48. Cluster randomized controlled trial: A matter of independence.
    Netuveli G
    Int J Qual Health Care; 2022 Apr; 34(2):. PubMed ID: 35349693
    [No Abstract]   [Full Text] [Related]  

  • 49. Erratum to: Adaptive goal setting and financial incentives: a 2 × 2 factorial randomized controlled trial to increase adults' physical activity.
    Adams MA; Hurley JC; Todd M; Bhuiyan N; Jarrett CL; Tucker WJ; Hollingshead KE; Angadi SS
    BMC Public Health; 2017 Apr; 17(1):303. PubMed ID: 28385148
    [No Abstract]   [Full Text] [Related]  

  • 50. Is a randomized controlled design sufficient for a trial to be valuable?
    Ubaldi FM; Cimadomo D; Vaiarelli A; Rienzi L
    Hum Reprod; 2021 Jul; 36(8):2416-2417. PubMed ID: 33993295
    [No Abstract]   [Full Text] [Related]  

  • 51. From methodology to data analysis: Prospects for the n = 1 intrasubject design.
    Glicksohn J
    Behav Brain Sci; 2004 Apr; 27(2):264-266. PubMed ID: 18241493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Which randomized controlled trial do we need?
    Leibovici L; Paul M; Doernberg SB
    Clin Microbiol Infect; 2022 Dec; 28(12):1525. PubMed ID: 36216239
    [No Abstract]   [Full Text] [Related]  

  • 53. Systematic investigation of scaled factorial cumulant moments for nucleus-nucleus interactions.
    Adamovich MI; Aggarwal MM; Alexandrov YA; Andreeva NP; Anson ZV; Arora R; Avetyan FA; Badyal SK; Basova E; Bazarov IK; Bhalla KB; Bhasin A; Bhatia VS; Bogdanov VG; Bubnov VI; Burnett TH; Cai X; Carshiev DA; Chasnicov IY; Chernova LP; Chernyavski MM; Eligbaeva GZ; Eremenko LE; Gaitinov AS; Ganssauge ER; Garpman S; Gerassimov SG; Grote JG; Gulamov KG; Gupta SK; Gupta VK; Heckman HH; Huang H; Jacobsson B; Judek B; Kachroo S; Kalyachkina GS; Kanygina EK; Karabova M; Kharlamov SP; Kitroo S; Koss T; Krasnov SA; Kumar V; Lal P; Larionova VG; Lepetan VN; Liu LS; Lokanathan S; Lord JJ; Lukicheva NS; Luo SB; Mangotra LK; Marutyan NA; Maslennikova NV; Mittra IS; Mookerjee S; Nasyrov SZ; Navotny VS; Nystrand J; Orlova GI; Otterlund I; Palsania H; Peresadko NG
    Phys Rev D Part Fields; 1993 May; 47(9):3726-3732. PubMed ID: 10015996
    [No Abstract]   [Full Text] [Related]  

  • 54. The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.
    Stampfer MJ; Buring JE; Willett W; Rosner B; Eberlein K; Hennekens CH
    Stat Med; 1985; 4(2):111-6. PubMed ID: 4023472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventions for preventing obesity in children.
    Brown T; Moore TH; Hooper L; Gao Y; Zayegh A; Ijaz S; Elwenspoek M; Foxen SC; Magee L; O'Malley C; Waters E; Summerbell CD
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001871. PubMed ID: 31332776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementing Clinical Research Using Factorial Designs: A Primer.
    Baker TB; Smith SS; Bolt DM; Loh WY; Mermelstein R; Fiore MC; Piper ME; Collins LM
    Behav Ther; 2017 Jul; 48(4):567-580. PubMed ID: 28577591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a conceptual framework for defining trial efficiency.
    Xie CX; De Simoni A; Eldridge S; Pinnock H; Relton C
    PLoS One; 2024; 19(5):e0304187. PubMed ID: 38781167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Hybrid Pragmatic and Factorial Cluster Randomized Controlled Trial for an Anti-racist, Multilevel Intervention to Improve Mental Health Equity in High Schools.
    Mulawa MI; Docherty SL; Bailey DE; Gonzalez-Guarda RM; Lipkus IM; Randolph SD; Yang Q; Pan W
    Prev Sci; 2024 Jul; 25(Suppl 3):486-496. PubMed ID: 38175459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Four 2×2 factorial trials of smartphone CBT to reduce subthreshold depression and to prevent new depressive episodes among adults in the community-RESiLIENT trial (Resilience Enhancement with Smartphone in LIving ENvironmenTs): a master protocol.
    Furukawa TA; Tajika A; Sakata M; Luo Y; Toyomoto R; Horikoshi M; Akechi T; Kawakami N; Nakayama T; Kondo N; Fukuma S; Noma H; Christensen H; Kessler RC; Cuijpers P; Wason JMS
    BMJ Open; 2023 Feb; 13(2):e067850. PubMed ID: 36828653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influential methods reports for group-randomized trials and related designs.
    Murray DM
    Clin Trials; 2022 Aug; 19(4):353-362. PubMed ID: 34991379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.